Market Samachar
Home  ›  GLOBAL
STAT · GLOBAL ·

Eli Lilly says Verve’s gene editor lowers cholesterol levels in early study - statnews.com

As reported by STAT
Eli Lilly said Monday that a high dose of its gene-editing therapy reduced cholesterol levels by 62% in participants in a clinical trial.
▸ MARKET SAMACHAR VIEW
NEUTRAL
Read full article on STAT ↗

Market Samachar is a news aggregator. This article was originally published by STAT. Tap the button above to read the full story on their site.

▸ EXPLORE MARKET SAMACHAR
Free tools for Indian retail investors — all built by us
📈Paper Trading

Trade NSE stocks with virtual coins. Build a portfolio, climb the leaderboard — zero real money.

Start trading ↗
🧠Quiz Master

1,500+ Indian market quiz questions. Earn coins per correct answer, climb leagues, build streaks.

Play now ↗
📊Market Move

Live gainers · losers · FII/DII · MTF · News Buzz. The complete Indian market dashboard.

View dashboard ↗
Pulse

Swipe BULL or BEAR on today's news. Earn +5 coins per swipe, +20 bonus when you're right.

Start swiping ↗

More from Market Samachar